Skip to search formSkip to main contentSkip to account menu

CH 55

Known as: CH-55, CH55 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Relaxant effect of all-trans-retinoic acid via NO-sGC-cGMP pathway and calcium-activated potassium channels in rat mesenteric artery.
Intraperitoneal injection of all-trans-retinoic acid (ATRA) results in a reduction of blood pressure in spontaneously… 
2001
2001
[The role of exogenous hRAR beta gene on the growth inhibition and differentiation induction of HL-60R Cells].
OBJECTIVE To investigate the role of hRAR beta gene in HL-60R cells and in their response to retinoids. METHODS By… 
1998
1998
Anticoagulant effects of synthetic retinoids.
We have recently found that retinoic acids (RAs) evoke anticoagulant effect by upregulating thrombomodulin (TM) and… 
1997
1997
Induction of the oxidative catabolism of retinoid acid in MCF-7 cells.
Cytochrome P450-dependent oxidation is a pathway for all-trans-retinoic acid (all-trans-RA) catabolism. Induction of this… 
1995
1995
Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells.
Retinoids stimulate tissue-type plasminogen-activator (t-PA) gene expression in human endothelial cells, and are likely to do so… 
1994
1994
In vitro effects of retinoic acid on mouse incisor development.
1994
1994
Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80.
all-trans-Retinoic acid (RA) is a potent inducer in vitro of the differentiation of the human acute myeloid leukemia cell line… 
1992
1992
Synthesis of a biospecific adsorbent for the purification of the three human retinoic acid receptors by affinity chromatography.
Review
1988
Review
1988
[Recent advances in retinoids studies].
Retinoids are defined as the compounds which elicit the specific biological responses through binding or activating the specific… 
1987
1987
Suppression of c-mos expression in teratocarcinoma cells with a new type of inducer of differentiation, 3,5-di-tert-butylchalcone 4'-carboxylic acid.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)